Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction

NCT03041259 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

320

Enrollment

INDUSTRY

Sponsor class

Conditions

Critical Limb Ischemia
Peripheral Arterial Disease

Interventions

DRUG: Rejuveinix Low Dose
DRUG: Rejuveinix High Dose

Sponsor

Reven Pharmaceuticals, Inc.